Zydus Lifesciences USFDA inspections
Zydus’s New Jersey office cleared a USFDA inspection with no observations; its Ahmedabad plant inspection concluded with one observation and no data-integrity-related findings. The company said it would work closely with the regulator.
Timeline
Tuesday, 29 September
- Zydus hits 52-week high, can the optimism continue?
Zydus Lifesciences has gained 32% in 2026
Monday, 28 September
- Zydus Life USFDA inspection at Ahmedabad plant concludes with 1 observation
The Ahmedabad plant inspection concluded with one observation; Zydus said there were no data integrity-related observations
Saturday, 26 September
- Zydus Lifesciences’ New Jersey office clears USFDA inspection with no observations
USFDA inspection concluded with nil observations